Drug intelligence / Profile preview

tert-butylhydroquinone

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral
01

Overview

tert-butylhydroquinone (TBHQ) is a synthetic aromatic organic compound, a type of phenol, and a derivative of hydroquinone. It is primarily utilized as an antioxidant preservative in the food, cosmetic, and pharmaceutical industries to prevent oxidation, inhibit lipid peroxidation, and extend the shelf life of various products. It functions by scavenging free radicals and is particularly effective in preventing rancidity in oils and fats. Beyond its preservative role, TBHQ has demonstrated biological activities, including enhancing Nrf2-mediated transcription by promoting the dissociation of Nrf2-Keap1, leading to Nrf2 stabilization and increased cellular antioxidant capabilities. Its oxidation product, tert-butylbenzoquinone (TBBQ), exhibits antibacterial activity by disrupting bacterial membrane integrity. Research also indicates its ability to stimulate AP-1 activation and matrix metalloproteinase-3 (MMP-3) expression, which has shown an aqueous outflow–enhancing effect in human donor eyes, suggesting potential therapeutic applications in conditions like glaucoma. Additionally, it has been investigated for its effects on estrogen receptor alpha (ERα) and tumor suppressor gene p53 in breast cancer cells, and for attenuating nephrotoxicity, hepatotoxicity, and neurotoxicity.

Brand names
Tenox TBHQ
Other names
tertiary butylhydroquinone2-(1,1-dimethylethyl)-1,4-benzenediol2-tert-Butyl-1,4-DihydroxybenzeneTert-Butyl HydroquinoneE319E-319E 319
02

Targets

KEAP1 (Kelch-like ECH-associated protein 1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on tert-butylhydroquinone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tert-butylhydroquinone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call